https://www.selleckchem.com/pr....oducts/auranofin.htm
ihr, Horvath-Rizea, Hekeler, Ganslandt, Henkes, Hoffmann, Scherlach and Schob.Objectives To assess the imaging biomarkers of glucose metabolic activity and diffusion-weighted imaging (DWI) derived from pretreatment integrated 18F-fluorodeoxyglucose positron emission tomography-magnetic resonance (18F-FDG PET/MR) imaging as potential predictive factors of metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Patients and Methods We retrospectively included 17 consecutive patients with pathologically confirmed PDAC by pre
Beğen
Yorum Yap
Paylaş
